FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

25327411000001101: Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Aug 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
80537901000001111 Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80538001000001113 Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet Is a Sumatriptan 50mg tablets 2 tablet true Inferred relationship Existential restriction modifier
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet Has AMP Migraitan 50mg tablets (Bristol Laboratories Ltd) true Inferred relationship Existential restriction modifier
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet Has specific active ingredient Sumatriptan succinate true Inferred relationship Existential restriction modifier
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sumatriptan true Inferred relationship Existential restriction modifier
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Migraitan 50mg tablets (Bristol Laboratories Ltd) 2 tablet Has basis of strength substance Sumatriptan true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start